血清可溶性Corin与高血糖关系的横断面研究
[Abstract]:Background: Diabetes is an important risk factor of cardiovascular and cerebrovascular diseases. It is an important disease burden and public health problem in our country. The mechanism for its pathogenesis is not fully set out. The Corin protein is a newly discovered serine protease that may be associated with the onset of cardiovascular disease. There are no studies on the relationship between the Corin protein and the blood glucose. Objective: To study the distribution of the serum Corin protein in the general population, to study the relationship between the Corin protein and the hyperglycemia, to provide an epidemiological basis for the study of the risk factors of diabetes in the population and the clinical treatment. Methods:4 rural communities and 4 urban communities in Suzhou's Suzhou region were randomly selected as the site of investigation by means of multi-stage cluster random sampling. According to the inclusion exclusion criteria, the last total of 2498 study subjects met the requirements. Data such as height, body weight and blood pressure were measured and recorded by trained qualified investigators using a uniform design questionnaire to collect data on demographic information, lifestyle risk factors, and disease history of the subject. Fasting venous blood was collected, and the indexes such as fasting blood glucose and blood fat were detected. The Corin protein and NT-proANP were tested in a laboratory using an ELISA kit. The relationship between Corin and hyperglycemia was analyzed by non-conditional logistic regression model. Age, systolic blood pressure, smoking, alcohol, total cholesterol and high density lipoprotein were adjusted at the time of the analysis to control the effect of these factors on the relationship between Corin and hyperglycemia. In order to exclude the potential effects of hypertension, overweight/ obesity, central obesity, or dyslipidemia on the results of hyperglycemia, a sensitivity analysis was performed. Results:1. In the 2498 subjects, there were 772 hyperglycaemia, with a prevalence of 30.90%. The prevalence of serum Corin in male was 1689.2 pg/ mL, the level of serum Corin in male was 2174.5 pg/ m L, and the female was 1515.1 pg/ m L. The male Corin level was significantly higher than that of the female (P0.001).3. The subjects were divided into four groups according to the different Corin quartiles of the male and female, and the number of overweight/ obese (prevalence) in the lower and high groups was 297 (47.52%),313 (50.16%),348 (55.86%) and 453 (72.36%), respectively. In the age and sex adjustment analysis, the risk of overweight/ obesity in the group 3 and 4 was 1.39-fold and 3.02-fold (all p0.05) in the first sub-group; in the multi-factor adjustment analysis, the risk of overweight/ obesity in the Corin level was 1.39-fold and 3.02-fold, respectively (all p0.05); in the multi-factor adjustment analysis, The corin level had a higher risk of overweight/ obesity in the 4-group study (or = 2.26, p0.001). The or value of overweight/ obesity increased with the increase of corin level, and the trend test was of statistical significance (p0.001). From the corin level of 1 to 4, the number of central obesity (prevalence) was 292 (46.72%),304 (48.72%),328 (52.65%) and 399 (63.74%), respectively. The OR values of the third and fourth sub-groups in the central obesity group were 1.29 (p = 0.033) and 2.34 (p0.05), respectively. After the multi-factor adjustment analysis, the central obesity or value of the fourth group was 1.74 times (p0.001) of the first sub-group. The central obesity or value also increased with the increase of corin (trend p = 0.001).4. The subjects were divided into 4 groups according to the corin4 division according to the different sex, and the number of hyperglycemia (prevalence) in the group from low to high (1,2,3, and 4) groups was 70 (29.17%),66 (27.39%),94 (38.84%) and 110 (46.03%), respectively. The univariate logistic analysis showed that the OR value (95% CI) of the 2,3 and 4 patients with hyperglycemia was 0.92 (0.62-1.36), 1.54 (1.06-2.26) and 2.07 (1.42-3.02), respectively, and the trend test was of statistical significance. The multivariate logistic regression analysis showed that the OR value (95% CI) of the 2,3, and 4 patients with hyperglycemia was 0.98 (0.68-1.47), 1.45 (0.97. 2.16) and 1.96 (1.29-2.96), respectively, with a statistical significance for the trend test, and the OR value of the 4-debitters was still of statistical significance (or = 1.96, p = 0.002). In women, the number of hyperglycemia (prevalence) in the 1,2,3 and 4 group was 87 (22.60%),95 (24.87%),118 (30.65%), and 132 (34.38%), respectively. The results of single factor analysis showed that the OR value (95% CI) of the 2,3 and 4 patients with hyperglycemia was 1.13 (0.81-1.58), 1.51 (1.10-2.09) and 1.79 (1.31-2.47), respectively. After multi-factor adjustment, the value (95% CI) of hyperglycemia in the 2,3 and 4 group was 1.08 (0.76-1.54), 1.28 (0.91-1.81) and 1.36 (0.97-1.91), respectively, with statistical significance (p = 0.050). Using the corin median as the limiting value, the subjects were divided into high corin group and low corin group, and the or value of hyperglycemia was calculated. The results showed that the hyperglycemia or the value of the high corin group was of statistical significance.5. The hypertension, overweight/ obesity, central obesity and dyslipidemia were excluded. The relationship between corin and hyperglycemia was analyzed. In the male, the single-factor analysis showed that the high corin group had a high or 2.3 (95% ci1.14-4.63), or 2.47 (95% ci1.11-5.50) after multi-factor adjustment. In the female, the single factor analysis showed that the value of the high corin group was 1.48; after the multi-factor adjustment, the cor value was 1.45.6, and the nt-protanp concentrations of the hyperglycemic and normal blood glucose groups in the male group were 1.09 (0.75-1.52) mmol/ L and 1.14 (0.73-1.64) mmol/ L, respectively, and the difference was not statistically significant; The NT-proANP in the group was 1.32 (0.88-1.85) and 1.34 (0.89-1.87) mmol/ L, respectively. Conclusion The relationship between serum Corin and hyperglycemia was reported in the general population of large samples for the first time in this study, and the serum Corin level in the hyperglycemic subjects was found to be high, and the prevalence of hyperglycemia increased with the increase of the level of Corin. The study suggests that serum Corin may play a role in sugar metabolism and may be a new risk factor for hyperglycemia. This study has found a new way to study the causes and pathogenesis of diabetes and to study the target of treatment.
【学位授予单位】:苏州大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R587.2
【相似文献】
相关期刊论文 前10条
1 刘赫;;波动性高血糖是独立的危险因素[J];实用糖尿病杂志;2006年06期
2 张建平;李香梅;温小玲;;吕梁市机关干部对高血糖防治知识了解状况的调查[J];护理研究;2009年20期
3 江糖;;醋与高血糖[J];实用糖尿病杂志;2010年05期
4 张永华;高血糖、高渗性非酮症昏迷误诊分析[J];山东医药;1989年04期
5 韩文铭,,万洪珠;肺心病急性发作期并发高血糖相关因素的分析[J];中国危重病急救医学;1995年05期
6 林风;;高血糖会增加患癌症概率[J];山西老年;2007年08期
7 ;为午睡后高血糖支招[J];糖尿病新世界;2007年10期
8 靳建鸣;;慎防春节高血糖[J];食品与健康;2009年01期
9 ;高血糖增加老痴危险[J];家庭医药(快乐养生);2013年06期
10 魏开敏;高血糖的危害种种[J];现代养生;2004年11期
相关会议论文 前10条
1 黄三利;;肺心病急性发作期高血糖的原因及处理[A];中华医学会急诊医学学会第六次全国急诊医学学术会议论文汇编[C];1996年
2 陈璐璐;;表观遗传修饰在高血糖“代谢记忆”中的作用[A];中华医学会第十二次全国内分泌学学术会议论文汇编[C];2013年
3 章瑶;韩亭亭;姜冬冬;李阳雪;胡耀敏;刘伟;;内科重症监护病房住院患者高血糖临床资料分析[A];中华医学会第十二次全国内分泌学学术会议论文汇编[C];2013年
4 张建中;景丽;马爱铃;王菲;于欣;;高血糖通过细胞外信号调节蛋白激酶1/2加重脑缺血性损伤[A];中华医学会病理学分会2006年学术年会论文汇编[C];2006年
5 童南伟;;中国成人住院患者高血糖管理目标的专家共识(征求意见稿)[A];中华医学会第十一次全国内分泌学学术会议论文汇编[C];2012年
6 张红霞;贾伟平;包玉倩;陆俊茜;陆惠娟;左玉华;杜颉;刘兰花;吴晓岭;顾惠林;项坤三;;高血糖人群糖尿病视网膜病变的流行病学研究[A];2006年中华医学会糖尿病分会第十次全国糖尿病学术会议论文集[C];2006年
7 何泉;陈安宝;陈嘉勇;;血糖控制对高血糖危象患者血单核细胞趋化蛋白MCP-1活性的影响[A];中华医学会急诊医学分会第十三次全国急诊医学学术年会大会论文集[C];2010年
8 韩晓菲;田慧;裴育;闫双通;方福生;钟文雯;肖靖;王传海;成晓玲;李晨曦;;老年患者住院期间发生严重高血糖情况分析[A];中华医学会糖尿病学分会第十六次全国学术会议论文集[C];2012年
9 廖云飞;陈璐璐;张冬雪;朱汉钢;;氧化应激关键酶在高血糖“代谢记忆”中的作用研究[A];中华医学会第十二次全国内分泌学学术会议论文汇编[C];2013年
10 张爱娟;;高血糖相关的发作性疾病[A];山东省2013年神经内科学学术会议暨中国神经免疫大会2013论文汇编[C];2013年
相关重要报纸文章 前10条
1 应明春;高血糖不等于糖尿病[N];中国消费者报;2003年
2 左佳;女性久坐着电视易患高血糖[N];农村医药报(汉);2007年
3 王建华;高血糖突然消失 未必是好事[N];家庭医生报;2007年
4 张洪军;高血糖 有时是用药不慎惹的祸[N];农村医药报(汉);2006年
5 张洪军;六类药易诱发高血糖[N];大众卫生报;2007年
6 佚名;高血糖会增加患癌症几率[N];农村医药报(汉);2007年
7 刘红;高血糖病例分析(一)[N];农村医药报(汉);2007年
8 刘红;高血糖病例分析(三)[N];农村医药报(汉);2007年
9 张锦星;高血糖危害大[N];大众卫生报;2000年
10 李凌;高血糖有什么危害[N];中国老年报;2003年
相关博士学位论文 前5条
1 谷鑫;基于TDS辅助诊断技术对不同体质类型“高血压合并MS、血脂紊乱合并MS、高血糖合并MS”人群经络特异性表达的研究[D];南京中医药大学;2015年
2 钟雪玉;微小RNA在高血糖“代谢记忆”中的作用及机制研究[D];华中科技大学;2015年
3 许文灿;高血糖促心脏连接蛋白43磷酸化及其对连接通道功能的影响[D];汕头大学;2008年
4 李彩娜;靶向GLP-1及其受体的抗糖尿病新药研究以及肥胖性MSG小鼠特征及其发生高血糖的机制研究[D];北京协和医学院;2011年
5 迟东升;急性高血糖和高血压对冠脉微血管血流调节影响的实验和临床研究[D];中国人民解放军第一军医大学;2003年
相关硕士学位论文 前10条
1 张婷婷;犬高血糖的临床诊断与治疗[D];西北农林科技大学;2015年
2 勉睿清;氧化应激参与高血糖抑制脑缺血后星形胶质细胞活化作用的研究[D];宁夏医科大学;2015年
3 夏新霞;院内高血糖的现况调查及其特点分析[D];山西医科大学;2015年
4 韩曙光;电磁场对高血糖动物电学特性和生物特性的影响[D];电子科技大学;2014年
5 周阳春;1、水通道蛋白3在高血糖促进胃癌进展中的作用 2、可切除胃癌患者术前血清CEA、CA19-9临床意义[D];南京医科大学;2015年
6 刘振;糖尿病和急性高血糖对缺血性脑卒中预后转归的影响[D];苏州大学;2015年
7 崔莎莎;高血糖合并房颤对急性脑梗死溶栓预后的影响[D];苏州大学;2016年
8 刘艳;血清可溶性Corin与高血糖关系的横断面研究[D];苏州大学;2016年
9 刘馨;肿瘤坏死因子-α介导高血糖加重脑缺血再灌注损伤的实验研究[D];宁夏医科大学;2013年
10 林锟;高血糖对小鼠卵母细胞、二细胞胚凋亡的影响[D];汕头大学;2010年
本文编号:2506788
本文链接:https://www.wllwen.com/yixuelunwen/nfm/2506788.html